Printer Friendly

Galderma Laboratories Launches New Mirvaso Topical Gel Pump Dispenser for Persistent Facial Redness of Rosacea.

M2 PHARMA-May 19, 2016-Galderma Laboratories Launches New Mirvaso Topical Gel Pump Dispenser for Persistent Facial Redness of Rosacea

(C)2016 M2 COMMUNICATIONS

- US-based dermatology and skin health spccialist Galderma Laboratories, L.P. has launched a new pump dispenser design for Mirvaso (brimonidine) Topical Gel, 0.33% for the treatment of the persistent facial redness associated with rosacea, the company said.

Galderma said that the Mirvaso Gel Pump is now available by prescription to patients in pharmacies nationwide in the US. The improved delivery system of the Mirvaso Gel Pump dispenses a consistent dose at each use.

Rosacea affects an estimated 16m Americans, and can often be a challenging condition to manage. Facial redness, also known as erythema, is an extremely common and frustrating symptom of rosacea, affecting up to 93% of sufferers.

There currently is no cure for rosacea, but proper treatment can help to control its signs and symptoms.

Originally approved by the US Food and Drug Administration in 2013, Mirvaso Gel is the first and only FDA-approved prescription medication for the treatment of the persistent facial redness of rosacea. Powerful, once-daily Mirvaso Gel works fast to reduce facial redness.

When applied once daily, it may start working in as little as 30 minutes and, for some, it can reduce redness for up to 12 hours.

Rosacea is a common inflammatory and vascular disorder, primarily affecting the face. Redness, visible blood vessels, bumps and pimples typically appear in the middle of the face (forehead, nose, cheeks) after age 30 in men and women with rosacea.

Because of the physical manifestation of rosacea on the face, the condition can cause embarrassment, anxiety and frustration, and can have a negative impact on the patients' social lives.

Stinging, burning and sensitivity of the skin are common, and in some cases, the eyes can become red, dry and itchy.

Common triggers for the condition include sun, extreme temperatures, spicy foods, alcohol, emotional stress, certain cosmetics and generally harmless, microscopic Demodex mites found on the skin.

If left untreated, rosacea may worsen. If people suspect that they might have rosacea, they should visit their dermatologist or healthcare provider for diagnosis and to discuss what treatment is right for them.

Dating back to 1961, Galderma is now present in 100 countries with a product portfolio to treat a range of dermatological conditions.

The company partners with health care professionals around the world to meet the skin health needs of people throughout their lifetime. Galderma is in research and development of scientifically-defined and medically-proven treatment options for the skin, hair and nails.

Its brands in the US include Epiduo Gel, Epiduo Forte Gel, Oracea Capsules, Clobex Spray, Differin Gel, Mirvaso Gel, MetroGel Gel, Soolantra Cream, Vectical Cream, Tri-Luma Cream, Cetaphil, Benzac Acne Solutions, Restylane, Restylane Silk, Restylane Lyft, Dysport (abobotulinumtoxinA) and Sculptra Aesthetic.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2016 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2016 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Date:May 19, 2016
Words:478
Previous Article:Hospira Launches LifeCare PCA 7.0 Infusion System.
Next Article:Oncology Company Novocure Enrolls Last Patient in Trial of Tumor Treating Fields in Ovarian Cancer.
Topics:

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |